Steven Lawrence McAfee MD

PubMed

• Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.
  Zachariah DeFilipp, Haesook T Kim, Laura W Knight, Suzanne M O'Connor, Shilton E Dhaver
  Blood. 2025-03-19
• Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
  Philip C Amrein, Frederic I Preffer, Geoffrey Fell, Eyal C Attar, Rupa Narayan
  Leukemia & Lymphoma. 2025-03-12
• 1 citations
  Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects.
  Richard A Newcomb, Lucy Gao, Julie Vanderklish, Alexandra Tse, Meredith Saylor
  Transplantation and Cellular Therapy. 2024-07-01

Abstracts/Posters

• Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic Diseases
  Steven L McAfee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
  Steven McAfee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Mye... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018